TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 27 filers reported holding TRACON PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $19,467 | -75.4% | 10,300 | -80.6% | 0.00% | – |
| Q4 2022 | $79,268 | -52.8% | 53,200 | -47.2% | 0.00% | – |
| Q3 2022 | $168,000 | -47.7% | 100,700 | -37.3% | 0.00% | -100.0% |
| Q2 2022 | $321,000 | -41.6% | 160,500 | -23.2% | 0.00% | 0.0% |
| Q1 2022 | $550,000 | -40.2% | 209,000 | -37.0% | 0.00% | -50.0% |
| Q4 2021 | $920,000 | -35.3% | 332,000 | -9.7% | 0.00% | -50.0% |
| Q3 2021 | $1,423,000 | -22.8% | 367,800 | +29.5% | 0.00% | -20.0% |
| Q2 2021 | $1,844,000 | -27.1% | 284,100 | -7.6% | 0.01% | -28.6% |
| Q1 2021 | $2,530,000 | -14.8% | 307,400 | +21.2% | 0.01% | -12.5% |
| Q4 2020 | $2,968,000 | +2622.9% | 253,700 | +357.9% | 0.01% | – |
| Q2 2020 | $109,000 | +395.5% | 55,400 | +326.2% | 0.00% | – |
| Q1 2020 | $22,000 | – | 13,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 4,125,322 | $8,251,000 | 3.72% |
| Ikarian Capital, LLC | 2,788,853 | $5,577,000 | 1.02% |
| Telemetry Investments, L.L.C. | 100,000 | $200,000 | 0.24% |
| ACT CAPITAL MANAGEMENT, LLC | 28,500 | $57,000 | 0.08% |
| JOHNSON & JOHNSON | 84,003 | $168,000 | 0.04% |
| NEA Management Company, LLC | 346,719 | $693,000 | 0.04% |
| X-Square Capital, LLC | 17,973 | $36,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 268,301 | $537,000 | 0.01% |
| LINDEN ADVISORS LP | 454,916 | $910,000 | 0.01% |
| DOWLING & YAHNKE LLC | 47,455 | $95,000 | 0.00% |